Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eclipse Medical Wellness vs Kin Meds

Eclipse Medical Wellness
Graded #259

Lower grade

vs+9.700000000000003
Kin Meds
Graded #75

Higher grade

The verdict

Kin Meds takes it — 72.9/100 to 63.2/100.

Kin Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKin Meds +29
45
74
Dose & formulationKin Meds +40
53
93
Clinical oversightEclipse Medical Wellness +14
88
74
Labs & monitoringEclipse Medical Wellness +24
77
53
FulfillmentKin Meds +7
65
72
Contract termsEven
55
55
Eclipse Medical Wellness · left barKin Meds · right bar

The numbers

MetricEclipse Medical WellnessKin Meds
WeighScore63.2/10072.9/100
GradeCC
Scorecard rank#259#75
SemaglutideNot disclosed$149/mo (brand Wegovy)
TirzepatideNot disclosed$149/mo (brand Zepbound)
Coverage1 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Eclipse Medical Wellness

Graded #259 · C

Strengths

  • Clinician-led care with baseline and quarterly lab monitoring included
  • Prescribes FDA-approved brand GLP-1 (Wegovy, Zepbound); compounded options also available
  • Transparent care-plan pricing ($749 3-month starter, ~$149/mo ongoing) with nutrition support
  • Includes a prior-authorization attempt plus dose-adjustment and side-effect monitoring

Where it loses points

  • Colorado residents only
  • Care-plan fees are separate from medication — you pay for the drug at your pharmacy
  • Prescription is not guaranteed (depends on clinical evaluation)
  • Small practice; no Terms or Privacy pages found on the site
Kin Meds

Graded #75 · C

Strengths

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Where it loses points

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard